Document is current

Any future updates will be listed below

Comparing Length of Stay Between Patients Taking Rivaroxaban and Conventional Anticoagulants for Treatment of Venous Thromboembolism

Crossref DOI link: https://doi.org/10.1007/s00408-016-9898-8

Published Online: 2016-05-18

Published Print: 2016-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark